Cellcyte Genetics Corp (CCYG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -164 | 586 | -359 | -799 | -1,420 |
| Depreciation Amortization | 17 | 15 | 16 | 55 | 156 |
| Accounts receivable | N/A | N/A | N/A | 26 | -26 |
| Accounts payable and accrued liabilities | 53 | 46 | -66 | 38 | -384 |
| Other Working Capital | 77 | 72 | -53 | 122 | -311 |
| Other Operating Activity | -45 | -797 | 317 | 478 | 1,955 |
| Operating Cash Flow | $-63 | $-78 | $-144 | $-80 | $-29 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 2 | N/A | 71 | 36 |
| Investing Cash Flow | $N/A | $2 | $N/A | $71 | $36 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 94 | 151 | 144 | 29 | 22 |
| Debt Repayment | N/A | N/A | N/A | N/A | 3 |
| Other Financing Activity | -31 | -75 | 0 | -28 | -31 |
| Financing Cash Flow | $63 | $76 | $144 | $2 | $-6 |
| Beginning Cash Position | N/A | N/A | N/A | 7 | 6 |
| End Cash Position | N/A | N/A | N/A | N/A | 7 |
| Net Cash Flow | $N/A | $N/A | $N/A | $-7 | $1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63 | -78 | -144 | -80 | -29 |
| Free Cash Flow | -63 | -78 | -144 | -80 | -29 |